The autologous platelet concentrates for maxillary sinus floor elevation: an overview of systematic reviews

Gong Jiaming,Zhao Ruimin,Zhang Qihang,Yu Zhanhai,Su Linhan
DOI: https://doi.org/10.12337/zgkqzzxzz.2023.04.006
2023-01-01
Abstract:Objective To evaluate the quality of methodology and evidence of the systematic reviews and meta-analyses(SR/MA) of autologous platelet concentrates(APC) for maxillary sinus floor elevation(MSFE). Methods PubMed, Embase,Cochrane Library, Scopus, CNKI, SinoMed, and WanFang databases were electronically searched to enroll SR/MA of APC for MSFE from inception to August 31, 2022. Two reviewers independently screened literature, extracted data, and employed the AMSTAR 2 and the GRADE for evaluating the quality of methodology of the included studies and the certainty of the evidence for outcomes respectively. Results A total of 13 SR/MA were included and the major conclusions were that APC presents limited influence on MSFE and might promote the healing of sinus tissue. The 9 items of AMSTAR 2 were reported well, and two items were not reported in any of the included SRs, and the quality was relatively convinced. The evidence grading of GRADE revealed that, in the total of 46 outcomes, 9 were graded as high-level, 25 as medium-level, 11 as low-level, and 1 as extremely low-level. Conclusion Most of the current evidence shows the advantages of APC in MSFE are not obvious, but the reliability of SR/Ma is inconsistent. High-quality clinical trials are still needed to verify the efficacy of APC for MSFE
What problem does this paper attempt to address?